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Lipid compositionPlasma membrane-derived vesicles are being used in biophysical and biochemical research as a simple, yet
native-like model of the cellular membrane. Here we report on the characterization of vesicles produced via
two different vesiculationmethods from CHO and A431 cell lines. The ﬁrst method is a recently developedmeth-
od which utilizes chloride salts to induce osmotic vesiculation. The second is a well established chemical vesicu-
lation method which uses DTT and formaldehyde. We show that both vesiculation methods produce vesicles
which contain the lipid species previously reported in the plasmamembrane of these cell lines. The twomethods
lead to small but statistically signiﬁcant differences in two lipid species only; phosphatidylcholine (PC) and
plasmalogen phosphatidylethanolamine (PEp). However, highly signiﬁcant differences were observed in the de-
gree of incorporation of a membrane receptor and in the degree of retention of soluble cytosolic proteins within
the vesicles.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The cellular plasma membrane, a complex assembly of lipids and
proteins, plays a critical role in cell physiology [1–4]. The membrane
provides the barrier, and mediates the communication, between the
cell and its environment. The processes that occur in the plasma mem-
brane, such as ion conduction, nutrients uptake, and signal transduction,
are critical for cell function [5–8]. It is often difﬁcult, however, to study
these processes in the plasma membrane of living cells, and thus bio-
physicists and biochemists often rely on model membrane systems.
One such model system is plasma membrane-derived vesicles, which
bud off cells in response to external stress [9,10]. These vesicles are de-
rived from the native cellular membrane, and are thus more native-like
than vesicles made of synthetic lipids. They are increasingly used in
studies of lipid–lipid, lipid–protein and protein–protein interactions,ester; MG, monoacylglycerol;
e; SM, sphingomyelin; dhSM,
fatide; GlcCer, glucosylceramide;
ide 3; PA, phosphatidic acid; PC,
hosphatidylethanolamine; PEp,
lycerol; PI, phosphatidylinositol;
etherphosphatidylcholine; LPE,
hosphatidylethanolamine; LPI,
cyl phosphatidylglycerol; NAPE,
gen phosphatidylethanolamine;and have already yielded new knowledge about lipid domains and re-
ceptor interactions in the membrane [11–15]. Often, however, they
are not well characterized in terms of their lipid and protein content.
The most widely used vesiculation method, developed in the 1960s,
utilizes the chemicals formaldehyde and dithiothreitol (DTT) to stress
the cells and to induce an apoptosis-like response [9,16,17]. Vesicles
can beproducedwith thismethod froma variety ofmammalian cells in-
cluding human embryonic kidney (HEK) 293 T cells, Chinese hamster
ovary (CHO) cells, A431 human epidermoid carcinoma cells, 3 T3 ﬁbro-
blasts, endothelial cells, a variety of other cancer cells, andmacrophages
[9,12,16–21]. These vesicles have been used widely in the literature to
study lipid domains, but concerns may arise in some cases due to the
presence of DTT, a reducing agent, as well as formaldehyde, a molecular
cross-linker. Thus, an alternative vesiculationmethod,whichutilizes os-
motic stress rather than chemicals, was recently developed [10]. In this
method, vesiculation is induced by incubating cells with a buffer which
contains high concentration of chloride salts. This osmotic method has
been used to produce vesicles from CHO and A431 cells, in the absence
of DTT and formaldehyde. The overall appearance of the vesicles pro-
duced with the osmotic stress method and the DTT/formaldehyde
method is very similar [10], and both vesicle preparations have been
used successfully in studies of protein interactions in membranes [18].
Here we sought to characterize and compare the vesicles produced
by chemical and osmotic vesiculation and to identify differences that
might exist between the two types of vesicles. In particular, we charac-
terized and compared A431 chloride salt vesicles and A431 DTT/
formaldehyde vesicles. As a control, we also characterized CHO DTT/
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vesiculation method and differences due to cell type.
2. Materials and methods
2.1. Cell culture and vesiculation
Chinese hamster ovary (CHO) and A431 cells were cultured in
T75 ﬂasks. These cells were vesiculated at 70% conﬂuency using a
DTT/formaldehyde buffer [9] or a chloride salt osmotic buffer [10].
2.2. Vesicle lipid pelleting
Centrifugationwas performed at 125×g, 4 °C to pellet the cell debris.
A second centrifugation was performed at 25,000 ×g for 45 min at 4 °C
to pellet the vesicles. The supernatant was discarded.
2.3. Liquid chromatography mass spectrometric (LC–MS) analysis of lipids
and cholesterol
Three independent samples were prepared for each vesicle type.
After pelleting, lipids and cholesterol were extracted as described
previously using a modiﬁed Bligh/Dyer procedure, spiked with ap-
propriate internal standards [22], and analyzed using a 6490 Triple
Quadrupole LC–MS system (Agilent Technologies, Santa Clara, CA).
Glycerophospholipids and sphingolipids were separated with
normal-phase HPLC as described before [22], with a few changes.
An Agilent Zorbax Rx-Sil column (inner diameter 2.1 × 100 mm)
was used under the following conditions: mobile phase A
(chloroform:methanol:1 M ammonium hydroxide, 89.9:10:0.1, v/v)
and mobile phase B (chloroform:methanol:water:ammonium hy-
droxide, 55:39.9:5:0.1, v/v); 95% A for 2 min, linear gradient to
30% A over 18 min and held for 3 min, and linear gradient to 95% A
over 2 min and held for 6 min. Sterols and glycerolipids were sepa-
rated with reverse-phase HPLC using an isocratic mobile phase as
before [22] except with an Agilent Zorbax Eclipse XDB-C18 column
(4.6 × 100 mm).
Quantiﬁcation of lipid species was accomplished using multiple
reaction monitoring (MRM) transitions [22] in conjunction with
referencing of appropriate internal standards: PA 14:0/14:0, PC
14:0/14:0, PE 14:0/14:0, PG 15:0/15:0, PI 16:0/16:0, PS 14:0/14:0,
BMP 14:0/14:0, APG 14:0/14:0, LPC 17:0, LPE 14:0, LPI 13:0, Cer
d18:1/17:0, SM d18:1/12:0, dhSM d18:0/12:0, GalCer d18:1/12:0,
GluCer d18:1/12:0, LacCer d18:1/12:0, D7-cholesterol, CE 17:0, MG
17:0, 4ME 16:0 diether DG, D5-TG 16:0/18:0/16:0 (Avanti Polar
Lipids, Alabaster, AL).
2.4. Thin layer chromatography
Thepelleted plasmamembrane vesicleswere resuspended in distilled
water. The solution was dried in a rotory evaporator and the lipids were
extracted using the Folch method with chloroform:methanol:distilled
water (2:1:1 (v/v)) at room temperature [23]. The extracts were dried
under a stream of N2 gas and resuspended in a chloroform:methanol
mixture (2:1 (v/v)). One dimensional thin layer chromatography
(TLC) was used to analyze the lipid content. Whatman ﬂexible silica
gel G plates were spotted with solutions containing the extracted
lipids, as well as the following lipid standards: 1-palmitoyl-2-
deoyl-sn-glycerol-3-phosphocholine (POPC), 1-palmitoyl-2-deoyl-
sn-glycerol-3-phospho-L-Serine (POPS), 1-palmitoyl-2-deoyl-sn-
glycerol-3-phosphoethanolamine (POPE), Sphingomyelin (from
Porcine brain), and cholesterol (Avanti Polar Lipids Inc). The plates
were then placed in a chamber with a chloroform:methanol:7-N
NH4OH (65:27:5 (v/v)) solution to separate the different lipid com-
ponents. After separation, the lipid components were visualized in
iodine vapor.2.5. 31P NMR phospholipid analysis
Vesicle pelletswere resuspended in distilledwater. The solutionwas
dried in a rotory evaporator and the lipids were extracted using the
Folch method with chloroform:methanol:distilled water (2:1:1 (v/v))
at room temperature [23]. The extracts were dried under a stream
of N2 gas and resuspended in a chloroform:methanol mixture (2:1
(v/v)). 20–30 mg of lipid extracts from each vesicle type were sent
to Avanti Polar Lipids Analytical Services for 31P NMR analysis. A
Bruker Avance™ III 400 mHz with a 5 mm BBFO Probe NMR spec-
trometer was used to characterize the phospholipid composition of
the samples dissolved in 1 mL of detergent.
2.6. Annexin V binding to plasma membrane derived vesicles
Vesicles were incubated for 1 h with ﬂuorescein-conjugated
Annexin V using the LI2004 Annexin V detection kit (Molecular Probes).
Images were recorded in a Nikon confocal microscope.
2.7. Plasmids for vesicle content leakage assays
The wild type human ﬁbroblast growth factor receptor 2 (FGFR2)
plasmid was a gift from Dr. Moosa Mohammadi (NYU). The FGFR2-
mCherry plasmid was constructed by fusing mCherry to the C-terminus
of full length FGFR2. The plasmid encoding 1-phosphatidylinositol 4,5-
bisphosphate phosphodiesterase delta-1-GFP (Plcδ1-PH-GFP) was ob-
tained from Dr. Tamas Balla (NIH). The plasmids encoding Intersectin
II-GFP, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase
gamma-1-GFP (Plcγ-GFP) and Protein kinase C theta-GFP (PKCΘ-GFP)
were a kind gift from Dr. Christoph Wuelﬁng (University of Bristol). The
Growth factor receptor-bound protein 2-Venus (Grb2-Venus) plasmid
was a gift from Dr. Jin Zhang (Johns Hopkins). The VVVVVV (Venus x
6) plasmid was purchased from Addgene (courtesy of Dr. Steven Vogel,
NIH).
2.8. Western blot analysis of EGFR in A431 vesicles
The vesicle pellets were lysed with lysis buffer (25 mM Tris–HCl,
0.5% Triton X-100, 20 mM NaCl, 2 mM EDTA, phosphatase inhibitor
and protease inhibitor, Roche Applied Science). The lysates were loaded
onto 3–8% NuPAGE®Novex®Tris–Acetatemini gels (Invitrogen, CA).
The proteins were transferred onto a nitrocellulose membrane, and
blocked using 5%milk in TBS. EGFRwas detected with anti-EGFR recep-
tor antibodies (2232 s, Cell Signaling Technology USA), followed by
anti-rabbit HRP conjugated antibodies (W4011, Promega). The proteins
were visualized with the Amersham ECL detection system (GE
Healthcare) as described previously [24,25].
2.9. EGF-Rhodamine binding to EGFR in A431 vesicles
Vesicles were incubated with 1ug/mL of Epidermal Growth Factor–
Tetramethylrhodamine Conjugate (E3481, Molecular Probes) for 1 h,
and were then imaged in the confocal microscope.
3. Results
3.1. Different methods of vesicle production lead to small, but statistically
signiﬁcant differences in cholesterol and lipid composition
We ﬁrst compared the lipid and cholesterol content of the three
types of vesicles used in this study: A431 chloride salt vesicles, A431
DTT/formaldehyde vesicles, and CHO DTT/formaldehyde vesicles using
liquid chromatography–mass spectrometry (LC–MS). Three indepen-
dent samples were prepared for each type of vesicle preparation. The
vesicles were pelleted and the lipids were extracted as described in
the Materials and methods section. The LC–MS results, shown in Fig. 1,
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Fig. 1. Cholesterol and lipid composition of A431 chloride salt vesicles, A431 DTT/formaldehyde vesicles, and CHO DTT/formaldehyde vesicles, determined by High Performance Liquid
Chromatography Mass Spectrometry (LC–MS). Shown are averages for three independent preparations, and the standard errors. FC: free cholesterol; CE: cholesteryl ester; MG:
monoacylglycerol; DG: diacylglycerol; TG: triacylglycerol; Cer: ceramide; SM: sphingomyelin; dhSM: dihydrosphingomyelin GalCer: galactosylceramide; Sulf: sulfatide; GlcCer:
glucosylceramide; LacCer: lactosylceramide; GM3: monosialodihexosylganglioside 3; PA: phosphatidic acid; PC: phosphatidylcholine; PCe: etherphosphatidylcholine; PE: phosphatidyl-
ethanolamine; PEp: plasmalogen phosphatidylethanolamine; PG: phosphatidylglycerol; PI: phosphatidylinositol; PS: diacylglycerol; LPC: lysophosphatidylserine; LPCe:
lysoetherphosphatidylcholine; LPE: lysophosphatidylethanolamine; LPEp: lysoplasmalogen phosphatidylethanolamine; LPI: lysophosphatidylinositol; BMP: bismonoacylglycerol; APG:
acyl phosphatidylglycerol; NAPE: N-Acyl phosphatidylethanolamine; NAPEp: N-Acyl plasmalogen phosphatidylethanolamine; NAPS: N-Acyl phosphatidylserine. Cholesterol is signiﬁ-
cantly different between A431 and CHO vesicles.
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three vesicle preparations. We found that the three types of vesicles
contain signiﬁcant amounts of free cholesterol (FC), phosphatidyl-
choline (PC), sphingomyelin (SM), phosphatidylethanolamine (PE),
phosphatidylserine (PS) and phosphatidylinositol (PI). Other sub-
stantial lipids are dhSM, PCe, PEp and LPC in A431 DTT/formaldehyde
vesicles, Cer, dhSM, PCe, PEp and LPC in A431 chloride salt vesicles,
and DG, GM3, dhSM, PCe, PEp and LPC in CHO DTT/formaldehyde
vesicles (see lipid annotations in Fig. 1).
Themole % of free cholesterol was 33.5±0.1, 30.4±1.4, and 22.5±
1.7 for A431 chloride salt, A431 DTT/formaldehyde, and CHO DTT/
formaldehyde vesicles, respectively. There was no statistically signiﬁ-
cant difference between the free cholesterol mole% in A431 chloride
salt and A431 DTT/formaldehyde vesicles (p = 0.09), based on a two-
tailed t-test. However, there was a statistically signiﬁcant difference be-
tween A431 DTT/formaldehyde vesicles and CHO DTT/formaldehyde
vesicles (p = 0.02).
Fig. 2 compares the lipid content of the three vesicle preparations.
As expected, the major lipid component in the three vesicle prepara-
tions was PC. There was a statistically signiﬁcant difference between
PC mole % in A431 chloride salt vesicles (43.8 ± 0.8 mol%) and A431
DTT/formaldehyde vesicles (51.0 ± 1.4 mol%) (p = 0.01). On the
other hand, the PC levels in A431 DTT/formaldehyde vesicles were
not different from CHO DTT/formaldehyde levels (55.5 ± 3.1 mol%)
(p =0.2).
The SM content in the A431 chloride salt vesicles, A431 DTT/
formaldehyde vesicles, and CHO DTT/formaldehyde vesicles was
7.2 ± 0.6 mol%, 7.7 ± 0.6 mol%, and 9.6 ± 0.5 mol% respectively.
No statistical differences were observed between SM mole % in
A431 chloride salt and A431 DTT/formaldehyde vesicles (p = 0.6),
or between A431 DTT/formaldehyde and CHO DTT/formaldehyde
vesicles (p = 0.07). Similarly, PI mole % was not signiﬁcantly differ-
ent in the three vesicle types.
PS content was 5.9 ± 0.6 mol% in A431 chloride salt vesicles, 6.5 ±
0.4 mol% in A431 DTT/formaldehyde vesicles, and 3.5 ± 0.1 mol% inCHO DTT/formaldehyde vesicles. The PS content was different in A431
DTT/formaldehyde and in CHO DTT/formaldehyde vesicles (p =
0.001) but not in A431 DTT/formaldehyde and A431 chloride salt vesi-
cles. Similarly, the PE content was similar in the two types of A431 ves-
icles, but different in the A431 and CHO vesicles.
Monosialodihexosylganglioside 3 (GM3) levels were not statistically
different in A431 chloride salt vesicles (0.3 ± 0.06 mol%) and in A431
DTT/formaldehyde vesicles (0.3 ± 0.08 mol%) (p = 0.7), but were
signiﬁcantly different when comparing A431 DTT/formaldehyde
(0.3 ± 0.08mol%) and CHO DTT/formaldehyde (1.9 ± 0.1 mol%) ves-
icles (p = 0.0003). This difference was most likely due to differences
in cellular membrane composition, as GM3 has been previously re-
ported in the plasma membranes of intact CHO cells [26], but not in
A431 cells [27].
Overall, the LC–MS results demonstrated that all vesicle prepara-
tions contain all the major lipids known to exist in plasma membranes
of intact cells.While therewere some statistically signiﬁcant differences
between lipids in A431 chloride salt vesicles and A431 DTT/formalde-
hyde vesicles, these differences appeared only in two lipid components,
namely PC and plasmalogen phosphatidylethanolamine (PEp). On the
other hand, signiﬁcant differences were observed between free choles-
terol, CE, GM3, dhSM, PE, PEp and PS levels when comparing A431 DTT/
formaldehyde and CHO DTT/formaldehyde vesicles, due to differences
in cell type.
The lipid composition of the three types of vesicleswas further stud-
ied using Thin Layer Chromatography (TLC) and 31P NMR. The TLC re-
sults, presented in Figure S1, show that cholesterol, PC, SM, PE, PS and
PI are present in all vesicle types.We also used the Avanti analytical ser-
vices to characterize the lipid composition of A431 chloride salt vesicles
and A431 DTT/formaldehyde vesicles with 31P NMR (spectra shown in
Figure S2). The analysis identiﬁed PC, PE, PI, PS, SM and LPE as the
major species in the A431 chloride salt vesicles, and PC, PE, PI, PS, SM,
LPE and LPC in the A431 DTT/formaldehyde vesicles (Fig. 3).
Overall, 31P NMR and TLC results were in agreementwith the LC–MS
results, since they identiﬁed the same major lipids as the LC–MS
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Fig. 2. Lipid composition of A431 chloride salt vesicles, A431 DTT/formaldehyde vesicles, and CHO DTT/formaldehyde vesicles, recalculated without cholesterol by re-scaling the LC–MS
data shown in Fig. 1. The major lipid component is PC, and there is a statistically signiﬁcant difference between PC abundance in A431 vesicles produced with the twomethods (chloride
salt andDTT/formaldehyde). There are also signiﬁcant differences in PEp abundance. Comparing A431 DTT/formaldehyde and CHODTT/formaldehyde samples, statistically signiﬁcant dif-
ferences are observed between PE, PS, GM3, dhSM, and PEp levels.
1594 S. Sarabipour et al. / Biochimica et Biophysica Acta 1848 (2015) 1591–1598experiments. They further conﬁrmed that PC is the major phospholipid
component in all vesicle preparations.
3.2. Vesicles bind annexin V, independent of production method
It is known that plasma membrane vesicles form as a result of cell
stress which induces an apoptotic response [16,17]. Under stress, the
cellular membrane loses some of its asymmetry, as PS, which is found
in the cytoplasmic leaﬂet of intact cells, becomes exposed on the cell
surface. As a result, the plasmamembrane derived-vesicles are expected
to have PS on their outer surfaces. Annexin V,which binds speciﬁcally to
PS, is therefore expected to bind to the vesicles [28]. Here we asked
whether we can detect differences in Annexin V binding due to vesicle
production. We thus incubated the vesicles with ﬂuorescently labeled
Annexin V. Fluorescence images, captured in the confocal microscope,
are shown in Fig. 4. We quantiﬁed and plotted the pixel intensities for
87 A431 DTT/formaldehyde vesicles and 52 A431 chloride salt vesicles.
The difference in parameters of the pixel intensities distributions for theFig. 3. Phospholipid content of the vesicles, from 31P NMR experiments performed by Avanti Po
each vesicle preparation. Qualitatively, the results are in agreement with the results in Fig. 2, wtwo types of vesicles was not statistically signiﬁcant. Thus, there were
no measurable differences in PS exposure to Annexin V due to produc-
tionmethod. In these experiments, no Annexin V bindingwas observed
to intact, non-apoptotic, un-vesiculated cells, which served as control.3.3. Cytoplasmic proteins are not retained in vesicles produced via osmotic
vesiculation
In our prior work, we have shown that soluble ﬂuorescent proteins,
expressed in CHO cells, ﬁll the DTT/formaldehyde vesicles [29]. In the
course of the current work we noticed, however, that the ﬂuorescent
proteins are not retained within chloride salt vesicles. To further inves-
tigate this phenomenon, we studied the retention of several soluble cy-
toplasmic proteins of different molecular weights, within the vesicles.
We labeled themembranes of cells and vesicles using Fibroblast Growth
Factor Receptor-(FGFR2)-mCherry, a ﬂuorescently tagged membrane
protein.lar Lipids Analytical Services (see Figure S2 for spectra). Single samples were analyzed for
ith PC being the most abundant phospholipid in the two samples.
Fig. 4. Annexin V binding to PS in (A) A431 chloride salt vesicles, (B) A431 DTT/formalde-
hyde vesicles, and (C) CHO DTT/formaldehyde vesicles. The method of vesicle production
does not have a signiﬁcant effect on Annexin V binding.
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~60 kDa). In this experiments, CHO cells were co-transfected with plas-
mids encoding for FGFR2-mCherry and Grb2-Venus. After expression,Fig. 5. Top panel: Chinese Hamster Ovary (CHO) expressing Grb2-Venus (MW ~ 60 kDa) and F
salt vesicles. Bottom panel: Grb2-Venus is retained in DTT/formaldehyde vesicles.FGFR2-mCherry was located on the membane, while Grb2-Venus ﬁlled
the cytoplasm. After vesiculation, Grb2-Venus (molecular weight
~60 kDa) was not found inside CHO chloride salt vesicles, but was
found inside the CHO DTT/formaldehyde vesicles. We next performed
experiments with proteins of higher molecular weight, PKCΘ-GFP
(MW ~ 120 kDa), Venus x 6 (MW ~ 160 kDa), Intersectin II-GFP
(MW ~ 170 kDa), and PLCγ-GFP (MW ~ 210 kDa). These are all soluble
proteins that reside in the cytoplasm of intact cells (Figure S3, B–F). As
shown in Figures S5–S7 and Fig. 6, noneof these proteinswere found in-
side the vesicles produced with the osmotic stress method.
In Fig. 6, we see that PLCγ-GFP (MW ~ 210 kDa) associates with the
plasma membrane in cells when FGFR2-mCherry is present because it
speciﬁcally interacts with it. Despite binding to FGFR2 in cells, however,
PLCγ-GFPwas not found in the choloride salt vesicles (Fig. 6). This likely
occurs because, upon vesiculation, PLCγ-GFP reaches a new equilibrium
with the aqueous sample volume which is effectively inﬁnite.
To conﬁrm that interactions with the membrane do not lead to sol-
uble protein retention in the chloride salt vesicles, we alsoworkedwith
Plcδ1-PH domain-GFP (MW ~ 45 kDa), which is known to bind to PIP2
in cells (Figure S3 A). As seen in Figure S6, Plcδ1-PH domain-GFP is not
retained inside the chloride salt vesicles, either. All above experiments
lead us to conclude that the chloride salt vesicles, unlike the DTT/form-
aldehyde vesicles, are ghost vesicles that lack cytoplasmic content.3.4. EGFR incorporates very efﬁciently in chloride salt vesicles, but not in
DTT/formaldehyde vesicles
Vesicles are derived from the plasma membranes of cells, and are
thus expected to contain membrane proteins, not only lipids. However,GFR2-mCherry. Middle panel: Grb2-Venus (MW ~ 60 kDa) is not retained in CHO chloride
Fig. 6. Top panel: CHO cells expressing Plcγ-GFP and FGFR2-mCherry. Bottom panel: Plcγ-GFP (MW ~ 210 kDa) is not retained in CHO chloride salt vesicles.
1596 S. Sarabipour et al. / Biochimica et Biophysica Acta 1848 (2015) 1591–1598it is not known if the incorporation ofmembrane proteins in the vesicles
in affected by the method of vesicle production. Since A431 cells are
known to express the epidermal growth factor receptor (EGFR) endog-
enously at high levels [30–32], we sought to compare the amount of
EGFR in the A431 vesicles produced with the twomethods usingWest-
ern blotting.
After vesiculation, we loaded identical amounts of total protein on
the gel, andwe visualized EGFR using anti-EGFR antibodies as described
in the Materials and methods section. The results are shown in Fig. 7.
While we see intense anti-EGFR bands in vesicles produces with the os-
motic stress method, we see very weak anti-EGFR staining in the vesi-
cles produces with the DTT/formaldehyde method. This ﬁnding
suggests that EGFR is not efﬁciently incorporated in the vesicles during
DTT/formaldehyde vesiculation, but is efﬁciently incorporated during
osmotic vesiculation.
To assess the functionality of EGFR in the two types of vesicles, we
investigated if the incorporated EGFR is capable of binding its ligand,
EGF. The vesicles were therefore incubated with ﬂuorescently labeled
EGF (EGF-Rhodamine), see Fig. 8. We observed that a large fraction171 kDa 
1 2
Fig. 7.Western blots results for endogenous Epidermal Growth Factor Receptor (EGFR) in
A431 vesicles. After vesicle lysis, identical amounts of total proteinwere loaded on the gel,
and EGFR bands were visualized using anti-EGFR antibodies as described in the Materials
and methods section. Lane 1: A431 chloride salt vesicles. Lane 2: A431 DTT/formaldehyde
vesicles.(~50–90%) of the A431/chloride salt vesicles was labeled. On the other
hand, only a small fraction of the A431 DTT/formaldehyde vesicles
(~5%) bind EGF-Rhodamine. This ﬁnding is consistentwith the observa-
tion that EGFR is not incorporated efﬁciently in the DTT/formaldehyde
vesicles. Yet, EGF-Rhodamine binding in Fig. 8 suggests that the recep-
tors in the two types of vesicles are capable of ligand binding.
4. Discussion
Here we characterized and compared A431 vesicles produced by
two different methods: osmotic vesiculation with chloride salts and
chemical vesiculation using DTT and formaldehyde. We also character-
ized CHO DTT/formaldehyde vesicles. The goal of these experiments
was to understand how differences due to productionmethod compare
with differences due to cell type.
Here we uncovered small but statistically signiﬁcant differences in
PC and PEp content, due to production method. On the other hand, sta-
tistically signiﬁcant differences in FC, CE, dhSM, GM3, PE, PEp and PS
were observed in A431 and CHO vesicles produced with the same
chemical vesiculation method. Thus, differences in cholesterol and
lipid content due to production method are quite modest, and smaller
than differences due to cell type.
We further demonstrated that the vesiculation method affects the
efﬁciency of incorporation of the membrane protein EGFR into the ves-
icles. In particular, EGFR incorporates easily into A431 chloride salt ves-
icles but is much less efﬁciently incorporated into DTT/formaldehyde
vesicles. Yet, prior work has demonstrated that other membrane
proteins such as GPA, Neu, and FGFR3 readily incorporate in DTT/
formaldehyde vesicles [13,14,33–35]. Thus, the incorporation efﬁcien-
cy of amembrane protein into the vesicles depends both on the produc-
tion method and on the identity of the membrane protein itself.
The most striking difference between chloride salt and DTT/
formaldehyde vesicles is in the degree of retention of soluble pro-
teins inside the vesicles. While soluble proteins are retained within
the DTT/formaldehyde vesicles, soluble proteins of molecular weight
up to 210 kDa are not found inside the chloride salt vesicles. An ex-
planation of this ﬁnding may be that formaldehyde cross-links cellu-
lar components and thus helps with the retention of soluble proteins
in the cytoplasm.
Fig. 8. EGF-Rhodamine binding to EGFR in A431 vesicles. Left: A341 chloride salt vesicles; Right: A431 DTT/formaldehyde vesicles.
1597S. Sarabipour et al. / Biochimica et Biophysica Acta 1848 (2015) 1591–1598Overall, we ﬁnd that plasma membrane-derived vesicles produced
by osmotic and chemical vesiculation are not identical models of the
cellular membrane. We therefore propose that parallel biophysical
characterization of membrane proteins in the two types of vesicles
maybehighly advantageous in some cases. Thus far, the interactions be-
tween TM helices have been characterized in the two types of vesicles
and have been shown to be similar [10,18]. Soluble proteins, however,
may interact with full-length membrane proteins and modulate their
behavior. While such effects are difﬁcult to quantify in live cells, they
could be assessed by quantifying differences in membrane protein in-
teractions in different vesicle preparations, in the presence and absence
of soluble proteins.
Conﬂict of interest
The authors have no conﬂict on interest.
Acknowledgements
This work was supported by NIH GM95930 and NSF MCB 1157687
to K.H., and NS056049 to G.D.P. We thank Drs. William Wimley, Ilya
Levental, Mark Lemmon, Gerald Feigenson, JeffreyMoore, Jose Luis San-
tos and Mr. Gregory Wiedman, Ms. Lolli Meeks and Ms. Lurong Pan for
helpful discussions. We thank Dr. Lijuan He for the vesicle pelleting
protocol.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2015.04.002.
References
[1] U. Coskun, K. Simons, Membrane rafting: from apical sorting to phase segregation, FEBS
Lett. 584 (2010) 1685–1693.
[2] A.H. Maddy, The organization of protein in the plasma membrane, in: K.B. Warren (Ed.),
Formation and Fate of Cell Organelles, Academic Press, New York and London 1967,
pp. 255–273.
[3] W. Stoeckenius, D.M. Engelman, Currentmodels for the structure of biologicalmembranes,
J. Cell Biol. 42 (1969) 613–646.
[4] T.E. Thompson, The properties of bimolecular phospholipid membranes, Cellular Mem-
branes in Development, Academic Press, New York 1964, pp. 83–96.
[5] S.H. White, A.S. Ladokhin, S. Jayasinghe, K. Hristova, Howmembranes shape protein struc-
ture, J. Biol. Chem. 276 (2001) 32395–32398.
[6] E. Neher, Ion channels for communication between and within cells, Neuron 8 (1992)
605–612.
[7] W.J. Fantl, D.E. Johnson, L.T. Williams, Signaling by receptor tyrosine kinases, Annu. Rev.
Biochem. 62 (1993) 453–481.[8] J. Bockaert, A. Dumuis, L. Fagni, P. Marin, GPCR-GIP networks: a ﬁrst step in the discovery
of new therapeutic drugs? Curr. Opin. Drug Discov. Devel. 7 (2004) 649–657.
[9] R.E. Scott, Plasma membrane vesiculation: a new technique for isolation of plasma mem-
brane, Science 194 (1976) 743–745.
[10] N. Del Piccolo, J. Placone, L. He, S.C. Agudelo, K. Hristova, Production of plasma mem-
brane vesicles with chloride salts and their utility as a cell membrane mimetic for bio-
physical characterization of membrane protein interactions, Anal. Chem. 84 (2012)
8650–8655.
[11] I. Levental, M. Grzybek, K. Simons, Raft domains of variable properties and compositions in
plasma membrane vesicles, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 11411–11416.
[12] S.L. Veatch, P. Cicuta, P. Sengupta, A. Honerkamp-Smith, D. Holowka, B. Baird, Critical ﬂuc-
tuations in plasma membrane vesicles, ACS Chem. Biol. 3 (2008) 287–293.
[13] L. Chen, L. Novicky, M. Merzlyakov, T. Hristov, K. Hristova, Measuring the energetics of
membrane protein dimerization in mammalian membranes, J. Am. Chem. Soc. 132
(2010) 3628–3635.
[14] J. Placone, K. Hristova, Direct assessment of the effect of the Gly380Arg achondroplasia
mutation on FGFR3 dimerization using quantitative imaging FRET, PLoS One 7 (2012)
e46678.
[15] N. Del Piccolo, J. Placone, K. Hristova, Effect of thanatophoric dysplasia type I mutations on
FGFR3 dimerization, Biophys. J. 108 (2015) 272–278.
[16] R.E. Scott, P.B. Maercklein, Plasma-membrane vesiculation in 3 T3-cells and Sv3T3 cells .2.
Factors affecting the process of vesiculation, J. Cell Sci. 35 (1979) 245–252.
[17] R.E. Scott, R.G. Perkins, M.A. Zschunke, B.J. Hoerl, P.B. Maercklein, Plasma-membrane vesic-
ulation in 3 T3-cells and Sv3T3-cells .1. Morphological and biochemical characterization, J.
Cell Sci. 35 (1979) 229–243.
[18] S. Sarabipour, K. Hristova, Glycophorin A transmembrane domain dimerization in plasma
membrane vesicles derived from CHO, HEK 293 T, and A431 cells, Biochim. Biophys. Acta
1828 (2013) 1829–1833.
[19] T. Baumgart, A.T. Hammond, P. Sengupta, S.T. Hess, D.A. Holowka, B.A. Baird, W.W. Webb,
Large-scale ﬂuid/ﬂuid phase separation of proteins and lipids in giant plasma membrane
vesicles, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 3165–3170.
[20] D. Holowka, B. Baird, Structural studies on the membrane-bound immunoglobulin e-
receptor complex.1. Characterization of large plasma-membrane vesicles from rat baso-
philic leukemia-cells and insertion of amphipathic ﬂuorescent-probes, Biochemistry 22
(1983) 3466–3474.
[21] P. Sengupta, A. Hammond, D. Holowka, B. Baird, Structural determinants for partitioning of
lipids and proteins between coexisting ﬂuid phases in giant plasma membrane vesicles,
Biochim. Biophys. Acta Biomembr. 1778 (2008) 20–32.
[22] R.B. Chan, T.G. Oliveira, E.P. Cortes, L.S. Honig, K.E. Duff, S.A. Small, M.R.Wenk, G.H. Shui, G.
Di Paolo, Comparative lipidomic analysis of mouse and human brain with Alzheimer dis-
ease, J. Biol. Chem. 287 (2012) 2678–2688.
[23] J. Folch, M. Lees, G.H. Sloan Stanley, A simple method for the isolation and puriﬁcation of
total lipides from animal tissues, J. Biol. Chem. 226 (1957) 497–509.
[24] L. He, W.A. Horton, K. Hristova, The physical basis behind achondroplasia, the most com-
mon form of human dwarﬁsm, J. Biol. Chem. 285 (2010) 30103–30114.
[25] L. He, K. Hristova, Pathogenic activation of receptor tyrosine kinases in mammalian mem-
branes, J. Mol. Biol. 384 (2008) 1130–1142.
[26] D.E. Warnock, C. Roberts, M.S. Lutz, W.A. Blackburn, W.W. Young, J.U. Baenziger, Determi-
nation of plasma-membrane lipid mass and composition in cultured Chinese-hamster
ovary cells using high-gradient magnetic afﬁnity-chromatography, J. Biol. Chem. 268
(1993) 10145–10153.
[27] B. Payrastre, M. Plantavid, C. Etievan, G. Ribbes, C. Carratero, H. Chap, L. Dousteblazy,
Characterization of plasma-membranes from A431 cells, isolated by self-generating
Percoll gradient—a rapid isolation procedure to obtain plasma-membranes with func-
tional epidermal growth-factor receptors, Biochim. Biophys. Acta 939 (1988)
355–365.
[28] F. Oling, J. Sopkova-de Oliveira Santos, N. Govorukhina, C. Mazères-Dubut, W. Bergsma-
Schutter, G. Oostergetel, W. Keegstra, O. Lambert, A. Lewit-Bentley, A. Brisson, Structure
of membrane-bound annexin A5 trimers: a hybrid cryo-EM–X-ray crystallography
study, J. Mol. Biol. 304 (2000) 561–573.
[29] E. Li, J. Placone, M. Merzlyakov, K. Hristova, Quantitative measurements of protein interac-
tions in a crowded cellular environment, Anal. Chem. 80 (2008) 5976–5985.
1598 S. Sarabipour et al. / Biochimica et Biophysica Acta 1848 (2015) 1591–1598[30] H. Haigler, J.F. Ash, S.J. Singer, S. Cohen, Visualization by ﬂuorescence of binding and inter-
nalization of epidermal growth-factor in human carcinoma cells A-431, Proc. Natl. Acad.
Sci. U. S. A. 75 (1978) 3317–3321.
[31] G. Carpenter, L. King, S. Cohen, Rapid enhancement of protein-phosphorylation in A-431
cell-membrane preparations by epidermal growth-factor, J. Biol. Chem. 254 (1979)
4884–4891.
[32] G. Carpenter, S. Cohen, Epidermal growth-factor, Annu. Rev. Biochem. 48 (1979) 193–216.[33] L. Chen, J. Placone, L. Novicky, K. Hristova, The extracellular domain of ﬁbroblast growth
factor receptor 3 inhibits ligand-independent dimerization, Science Signaling, 32010. ra86.
[34] J. Placone, L. He, N. Del Piccolo, K. Hristova, Strong dimerization of wild-type ErbB2/Neu
transmembrane domain and the oncogenic Val664Glu mutant in mammalian plasma
membranes, Biochim. Biophys. Acta 1838 (2014) 2326–2330.
[35] S. Sarabipour, K. Hristova, FGFR3 transmembrane domain interactions persist in the pres-
ence of its extracellular domain, Biophys. J. 105 (2013) 165–171.
